Alpha and Omega Semiconductor Li (NASDAQ: AOSL) stock suffered a major decline of -15.4% on 11/7/23. The shares closed at $21.53. The stock has declined -8.3% during the last week but has been exceptionally strong […]
Gen Digital Inc (NASDAQ: GEN) has reported E.P.S. of $0.23 for its second fiscal quarter (ending September 30) versus $0.12 for the same period a year ago — an increase of 92%. For the latest […]
Axon Enterprise Inc (NASDAQ: AXON) has reported earnings for its third fiscal quarter (ending September 30) of $0.79 versus $0.17 for the same period a year ago — an increase of 365%. This performance was […]
Surgery Partners Inc (NASDAQ: SGRY) has reported E.P.S. of $-0.04 for its third fiscal quarter (ending September 30) versus $-0.28 for the same period a year ago. This result fell short of the consensus estimate […]
On 11/7/23, Biomarin Pharmaceutical Inc (NASDAQ: BMRN) stock enjoyed a major increase of 12.2%, closing at $85.49. Relative to the market the stock has been weak over the last nine months but has risen 5.6% […]
MFA Financial Inc (NYSE: MFA) has reported E.P.S. of $-0.64 for its third fiscal quarter (ending September 30) versus $-0.62 for the same period a year ago. This performance was $-1.02 short of the consensus […]
Innospec Inc (NASDAQ: IOSP) has reported earnings for its third fiscal quarter (ending September 30) of $1.58 versus $1.56 for the same period a year ago — an increase of 1%. This result exceeded the […]
For its third fiscal quarter (ending September 30), Viatris Inc (NASDAQ: VTRS) has reported a -3% decline in E.P.S. from $0.29 a year ago to $0.28 in the current quarter. This performance was $-0.46 short […]
Ingredion Inc (NYSE: INGR) has reported E.P.S. of $2.39 for its third fiscal quarter (ending September 30) versus $1.61 for the same period a year ago — an increase of 48%. Relative to the consensus […]
Xencor Inc (NASDAQ: XNCR) has reported E.P.S. of $-0.40 for its third fiscal quarter (ending September 30) versus $-0.55 for the same period a year ago. This performance was $0.31 better than the consensus estimate […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research